display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic/advanced - colorectal cancer (mCRC)
metastatic/advanced - colorectal cancer (mCRC)
atezolizumab plus SoC Modul Cohort 2

Study type: